“The company is looking at all of its options, but we have made no decisions, and have not set any timetables,” a Purdue spokesperson told Bloomberg.
The Oklahoma trial will start in May, and state attorneys general are seeking to recover as much as $25 billion to address current and future costs of dealing with the opioid epidemic.
Purdue executives said they are disappointed by the judge’s decision and argue that the Oklahoma attorney general’s office has failed to turn over thousands of documents, which has “unfairly prejudiced Purdue’s ability to adequately prepare our defenses.”
Oklahoma lawmakers claim that Purdue repeatedly has threatened to file for bankruptcy to get out of facing a jury. They say Purdue wants to delay the trial to get more time to prepare its Chapter 11 case.
Read the full report here.
More articles on pharmacy:
Bristol-Myers urges shareholders to support Celgene takeover
Novartis to pay $23M to settle claims it used charity payments as kickbacks
Martin Shkreli reportedly running his pharma company from prison
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.